Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 55:849-855, 2006
DOI: 10.2337/diabetes.55.03.06.db05-1418
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow Erratum (v55,p1904)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sun, M. W.
Right arrow Articles by Florez, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, M. W.
Right arrow Articles by Florez, J. C.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Brief Genetics Reports

Haplotype Structures and Large-Scale Association Testing of the 5' AMP-Activated Protein Kinase Genes PRKAA2, PRKAB1, and PRKAB2 With Type 2 Diabetes

Maria W. Sun1,2, Jennifer Y. Lee1,2, Paul I.W. de Bakker1,2,3, Noël P. Burtt2, Peter Almgren4, Lennart Råstam5, Tiinamaija Tuomi6, Daniel Gaudet7, Mark J. Daly2,8, Joel N. Hirschhorn2,3,9, David Altshuler1,2,3,8,10, Leif Groop4,6, and Jose C. Florez1,2,8,10

1 Department of Molecular Biology, Massachusetts General Hospital, Boston, Massachusetts
2 Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts
3 Department of Genetics, Harvard Medical School, Boston, Massachusetts
4 Department of Endocrinology, University Hospital MAS, Lund University, Malmö, Sweden
5 Department of Clinical Science, University Hospital MAS, Lund University, Malmö, Sweden
6 Department of Medicine, Helsinki University Central Hospital, Folkhalsan Genetic Institute, Folkhalsan Research Center and Research Program for Molecular Medicine, University of Helsinki, Helsinki, Finland
7 University of Montreal Community Genomic Center, Chicoutimi Hospital, Quebec, Canada
8 Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts
9 Divisions of Genetics and Endocrinology, Children’s Hospital, Boston, Massachusetts
10 Department of Medicine, Harvard Medical School, Boston, Massachusetts

Address correspondence and reprint requests to Jose C. Florez, Diabetes Unit/Dept. of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114. E-mail: jcflorez{at}partners.org

Abbreviations: AMPK, AMP-activated protein kinase; GRR, genotype relative risk; ISI, insulin sensitivity index; LD, linkage disequilibrium; MAF, minor allele frequency; OGTT, oral glucose tolerance test; PPAR, peroxisome proliferator–activated receptor; SNP, single nucleotide polymorphism

AMP-activated protein kinase (AMPK) is a key molecular regulator of cellular metabolism, and its activity is induced by both metformin and thiazolidinedione antidiabetic medications. It has therefore been proposed both as a putative agent in the pathophysiology of type 2 diabetes and as a valid target for therapeutic intervention. Thus, the genes that encode the various AMPK subunits are intriguing candidates for the inherited basis of type 2 diabetes. We therefore set out to test for the association of common variants in the genes that encode three selected AMPK subunits with type 2 diabetes and related phenotypes. Of the seven genes that encode AMPK isoforms, we initially chose PRKAA2, PRKAB1, and PRKAB2 because of their higher prior probability of association with type 2 diabetes, based on previous reports of genetic linkage, functional molecular studies, expression patterns, and pharmacological evidence. We determined their haplotype structure, selected a subset of tag single nucleotide polymorphisms that comprehensively capture the extent of common genetic variation in these genes, and genotyped them in family-based and case/control samples comprising 4,206 individuals. Analysis of single-marker and multi-marker tests revealed no association with type 2 diabetes, fasting plasma glucose, or insulin sensitivity. Several nominal associations of variants in PRKAA2 and PRKAB1 with BMI appear to be consistent with statistical noise.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Med. Genet.Home page
N J Spencer-Jones, D Ge, H Snieder, U Perks, R Swaminathan, T D Spector, N D Carter, and S D O'Dell
AMP-kinase {alpha}2 subunit gene PRKAA2 variants are associated with total cholesterol, low-density lipoprotein-cholesterol and high-density lipoprotein-cholesterol in normal women
J. Med. Genet., December 1, 2006; 43(12): 936 - 942.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Saxena, L. Gianniny, N. P. Burtt, V. Lyssenko, C. Giuducci, M. Sjogren, J. C. Florez, P. Almgren, B. Isomaa, M. Orho-Melander, et al.
Common Single Nucleotide Polymorphisms in TCF7L2 Are Reproducibly Associated With Type 2 Diabetes and Reduce the Insulin Response to Glucose in Nondiabetic Individuals.
Diabetes, October 1, 2006; 55(10): 2890 - 2895.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
N. Tiffin, E. Adie, F. Turner, H. G. Brunner, M. A. van Driel, M. Oti, N. Lopez-Bigas, C. Ouzounis, C. Perez-Iratxeta, M. A. Andrade-Navarro, et al.
Computational disease gene identification: a concert of methods prioritizes type 2 diabetes and obesity candidate genes
Nucleic Acids Res., June 6, 2006; 34(10): 3067 - 3081.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.